Back to Search Start Over

Risk of type 2 diabetes according to traditional and emerging anthropometric indices in Spain, a mediterranean country with high prevalence of obesity: results from a large-scale prospective cohort study

Authors :
José María Huerta
Carmen Navarro
María Dolores Chirlaque
Carlos González
Michelle A. Mendez
María José Sánchez
Eva Ardanaz
Esther Molina-Montes
Diego Salmerón
Nerea Larrañaga
Conchi Moreno-Iribas
María José Tormo
Larraitz Arriola
José Ramón Quirós
Pilar Amiano
Aurelio Barricarte
Diana Gavrila
Rosana Burgui
Miren Dorronsoro
Estefanía Toledo
Laudina Rodríguez
Noémie Travier
[Huerta,JM
Tormo,MJ
Chirlaque,MD
Gavrila,D
Salmerón,D
Navarro,C] Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain. [Huerta,JM
Amiano,P
Arriola,L
Ardanaz,E
Sánchez,MJ
Barricarte,A
Burgui,R
Dorronsoro,M
Larrañaga,N
Molina-Montes,E
Moreno-Iribas,C
Navarro,C] CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.[Tormo,MJ
Navarro,C] Department of Sociosanitary Sciences, University of Murcia School of Medicine, Murcia, Spain. [Amiano,P
Larrañaga,N] Public Health Department of Gipuzkoa, Basque Government, San Sebastián, Spain. [Ardanaz,E
Toledo,E] Public Health Institute of Navarra, Pamplona, Spain. [Rodríguez,L
Quirós,JR] Public Health Directorate, Asturias, Spain. [Sánchez,MJ
Molina-Montes,E] Andalusian School of Public Health, Granada, Spain. [Mendez,M] Center for Environmental Epidemiology Research, Barcelona, Spain. [Moreno-Iribas,C] Autonomous University of Barcelona, Barcelona, Spain. [Toledo,E] University of Navarra, Pamplona, Spain. [Travier,N
González,CA] Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Barcelona, Spain.
This work was supported by the SENECA Foundation (15414/PI/10) and the EPIC-InterAct study (LSHM-CT-2006-037197). The EPIC study received financial support from the International Agency for Research on Cancer (AEP/93/06), the European Commission (SO-97-200302-05F02, SP23-CT-2005-006438), the Health Research Fund (FIS) of the Spanish Ministry of Health, the Red Temática de Investigación Cooperativa de Centros de Cáncer (RTICCC C03/10, RD06/0020), the CIBER de Epidemiología y Salud Pública (CIBERESP), the participating Regional Governments of Andalusia, Asturias, Basque Country, Murcia (no. 6236), and Navarra, and the Catalan Institute of Oncology.
Source :
BMC Endocrine Disorders, Vol 13, Iss 1, p 7 (2013), BMC Endocrine Disorders, Dadun. Depósito Académico Digital de la Universidad de Navarra, instname
Publication Year :
2013
Publisher :
BioMed Central, 2013.

Abstract

Background Obesity is a major risk factor for type 2 diabetes mellitus (T2DM). A proper anthropometric characterisation of T2DM risk is essential for disease prevention and clinical risk assessement. Methods Longitudinal study in 37 733 participants (63% women) of the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort without prevalent diabetes. Detailed questionnaire information was collected at baseline and anthropometric data gathered following standard procedures. A total of 2513 verified incident T2DM cases occurred after 12.1 years of mean follow-up. Multivariable Cox regression was used to calculate hazard ratios of T2DM by levels of anthropometric variables. Results Overall and central obesity were independently associated with T2DM risk. BMI showed the strongest association with T2DM in men whereas waist-related indices were stronger independent predictors in women. Waist-to-height ratio revealed the largest area under the ROC curve in men and women, with optimal cut-offs at 0.60 and 0.58, respectively. The most discriminative waist circumference (WC) cut-off values were 99.4 cm in men and 90.4 cm in women. Absolute risk of T2DM was higher in men than women for any combination of age, BMI and WC categories, and remained low in normal-waist women. The population risk of T2DM attributable to obesity was 17% in men and 31% in women. Conclusions Diabetes risk was associated with higher overall and central obesity indices even at normal BMI and WC values. The measurement of waist circumference in the clinical setting is strongly recommended for the evaluation of future T2DM risk in women.

Details

Language :
English
Database :
OpenAIRE
Journal :
BMC Endocrine Disorders, Vol 13, Iss 1, p 7 (2013), BMC Endocrine Disorders, Dadun. Depósito Académico Digital de la Universidad de Navarra, instname
Accession number :
edsair.doi.dedup.....088c1679f15f1ad1d978adc1a2205a72